Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imma Forzano

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Top Italian Scientists Journal|April 8, 2024
Patent Foramen Ovale: The Unresolved QuestionsImma Forzano, Gaetano Santulli
Cardiovascular Research|April 24, 2023
A machine learning model identifies a functional connectome signature that predicts blood pressure levels: imaging insights from a large population of 35 882 patientsRoberta Avvisato, Imma Forzano, Fahimeh Varzideh, et al.
Critical Care Medicine|January 8, 2025
Beneficial Effects of Early Rehabilitation in Patients With Acute Heart FailureImma Forzano, Scott Wilson, Emanuele Farroni, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 2025
Macrophages Regulate Inflammatory Vascular Remodeling in Pulmonary HypertensionFahimeh Varzideh, Imma Forzano, Emanuele Farroni, et al.
International Journal of Molecular Sciences|December 11, 2022
Tirzepatide: A Systematic UpdateImma Forzano, Fahimeh Varzideh, Roberta Avvisato, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failureFahimeh Varzideh, Pasquale Mone, Luigi Salemme, et al.
Frontiers in Endocrinology|December 26, 2022
The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertensionImma Forzano, Pasquale Mone, Fahimeh Varzideh, et al.
JACC. Case Reports|January 24, 2026
Invasive Diagnosis of HFpEF and ANOCA in a Patient With Effort Dyspnea and AnginaImma Forzano, Giuseppe Gargiulo, Lina Manzi, et al.
Expert Opinion on Investigational Drugs|September 23, 2023
SGLT2 inhibitors: an evidence-based update on cardiovascular implicationsImma Forzano, Scott Wilson, Angela Lombardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2023
Long-Lasting Control of LDL Cholesterol Induces a 40% Reduction in the Incidence of Cardiovascular Events: New Insights from a 7-Year StudyValentina Trimarco, Raffaele Izzo, Paola Gallo, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Top Italian Scientists Journal|April 8, 2024
Patent Foramen Ovale: The Unresolved QuestionsImma Forzano, Gaetano Santulli
Cardiovascular Research|April 24, 2023
A machine learning model identifies a functional connectome signature that predicts blood pressure levels: imaging insights from a large population of 35 882 patientsRoberta Avvisato, Imma Forzano, Fahimeh Varzideh, et al.
Critical Care Medicine|January 8, 2025
Beneficial Effects of Early Rehabilitation in Patients With Acute Heart FailureImma Forzano, Scott Wilson, Emanuele Farroni, et al.
Hypertension (Dallas, Tex. : 1979)|February 19, 2025
Macrophages Regulate Inflammatory Vascular Remodeling in Pulmonary HypertensionFahimeh Varzideh, Imma Forzano, Emanuele Farroni, et al.
International Journal of Molecular Sciences|December 11, 2022
Tirzepatide: A Systematic UpdateImma Forzano, Fahimeh Varzideh, Roberta Avvisato, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failureFahimeh Varzideh, Pasquale Mone, Luigi Salemme, et al.
Frontiers in Endocrinology|December 26, 2022
The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertensionImma Forzano, Pasquale Mone, Fahimeh Varzideh, et al.
JACC. Case Reports|January 24, 2026
Invasive Diagnosis of HFpEF and ANOCA in a Patient With Effort Dyspnea and AnginaImma Forzano, Giuseppe Gargiulo, Lina Manzi, et al.
Expert Opinion on Investigational Drugs|September 23, 2023
SGLT2 inhibitors: an evidence-based update on cardiovascular implicationsImma Forzano, Scott Wilson, Angela Lombardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2023
Long-Lasting Control of LDL Cholesterol Induces a 40% Reduction in the Incidence of Cardiovascular Events: New Insights from a 7-Year StudyValentina Trimarco, Raffaele Izzo, Paola Gallo, et al.
Pageof 3